Dexcom (DXCM) EBT Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Dexcom (DXCM) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -429.00 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 803.00 |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 260.00 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 574.00 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 764.00 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 835.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -1,045.00 |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 598.00 |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 423.00 |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | -309.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 598.00 |
| Mar 31, 2026 | 1,391.00 |
| Dec 31, 2025 | 1,071.00 |
| Sep 30, 2025 | 1,014.00 |
| Jun 30, 2025 | 1,002.00 |
| Mar 31, 2025 | 915.00 |
| Dec 31, 2024 | 1,806.00 |
| Sep 30, 2024 | 62.00 |
| Jun 30, 2024 | 238.00 |
| Mar 31, 2024 | 621.00 |
| Dec 31, 2023 | -331.00 |
| Sep 30, 2023 | 966.00 |
| Jun 30, 2023 | 806.00 |
| Mar 31, 2023 | 317.00 |
| Dec 31, 2022 | -404.00 |
| Sep 30, 2022 | 744.00 |
| Jun 30, 2022 | 1,358.00 |
| Mar 31, 2022 | 1,522.00 |
| Dec 31, 2021 | 5,325.00 |
| Sep 30, 2021 | 43.00 |